Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
BAVENCIO® (avelumab) | For Healthcare Professionals
See risks and benefits of BAVENCIO® (avelumab). Get HCP info & learn how BAVENCIO may treat metastatic Merkel cell carcinoma & previously treated advanced urothelial cancer.
This website is hosted with Akamai Technologies, Inc., which reserves the following IP addresses for bavencio.com: 104.70.52.21. Moreover, DNS used with this website include ns1.brandshelter.com, ns2.brandshelter.de, ns3.brandshelter.info, ns4.brandshelter.net, ns5.brandshelter.us. Subnet identifier ranges from 104.64.0.0 to 104.127.255.255. Classless Inter-Domain Routing (CIDR) is 104.64.0.0/10. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1.brandshelter.com
ns2.brandshelter.de
ns3.brandshelter.info
ns4.brandshelter.net
ns5.brandshelter.us
{{value}}
2011-12-15
2023-12-15
REDACTED FOR PRIVACY
KEY-SYSTEMS GMBH
info@domain-contact.org
{{value}}
The registrar of bavencio.com is KEY-SYSTEMS GMBH and the name expires on 2023-12-15. According to open source data, you can reach the owner at info@domain-contact.org but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A